Showing results (81-90 of 589) with videos related to
Sort By:
Pageof 59
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1990
Current problems and future requirements for 5-hydroxytryptamine receptor classificationG R MartinCephalalgia : an International Journal of Headache|December 17, 1997
Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraineG R MartinPharmacology & Therapeutics|January 1, 1994
Vascular receptors for 5-hydroxytryptamine: distribution, function and classificationG R MartinEuropean Neurology|January 1, 1996
Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of actionG R MartinBritish Journal of Pharmacology|March 1, 1985
Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atriumJ W Black, V P Gerskowitch, P Leff, et al.Neuroscience|October 24, 2001
Orphanin-FQ/nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibitionR Gutiérrez, P Leff, H Romo-Parra, et al.Trends in Pharmacological Sciences|February 1, 1990
Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?P Leff, I G Dougall, D H Harper, et al.British Journal of Pharmacology|February 29, 2000
ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptorsG E Jarvis, R G Humphries, M J Robertson, et al.British Journal of Pharmacology|November 1, 1986
Analysis of competitive antagonism when this property occurs as part of a pharmacological resultantJ W Black, V P Gerskowitch, P Leff, et al.Journal of the Autonomic Nervous System|June 28, 2000
Adventures in the pharmacological analysis of P2 receptorsM S Fagura, G E Jarvis, I G Dougall, et al.Pageof 59